Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma
Aims. To evaluate the expression of DSG1 and DSG2 and investigate their clinicopathological significance in EHCC. Method. The protein expression of DSG1 and DSG2 was measured by EnVision immunohistochemistry in 15 normal biliary tract tissues, 10 biliary tract adenoma tissues, 30 peritumoral tissues...
Saved in:
Main Authors: | Shu Xu, Shengfu Huang, Daiqiang Li, Qiong Zou, Yuan Yuan, Zhulin Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.1155/2020/9831646 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Superficial Dsg2 Expression Limits Epidermal Blister Formation Mediated by Pemphigus Foliaceus Antibodies and Exfoliative Toxins
by: Donna Brennan, et al.
Published: (2010-01-01) -
Four cardiomyopathy patients with a heterozygous DSG2 p.Arg119Ter variant
by: Takuya Sumida, et al.
Published: (2024-12-01) -
Diagnostic cholangioscopy for surgical planning of extrahepatic cholangiocarcinoma
by: Min Je Sung, et al.
Published: (2025-01-01) -
Metformin Use and Survival in Patients with Advanced Extrahepatic Cholangiocarcinoma: A Single-Center Cohort Study in Fuyang, China
by: Jinqing Wu, et al.
Published: (2021-01-01) -
Predicting survival rates: the power of prognostic nomograms in distal cholangiocarcinoma
by: Jiangfeng Hu, et al.
Published: (2025-01-01)